Neurotransmission is a fundamental process of communication within the body. Without neurotransmission, the central and peripheral nervous system cannot process the information appropriately. Neurotransmitters are essential for cognition, emotions, movement, sensory perception, activities of the autonomic nervous system, hormonal regulation, and all the homeostatic mechanisms within the body. This Special Issue highlights the numerous fields of research around the theme of neurotransmission, from behavior, neuropeptides, innervation of the uterus, neurotoxic agents, novel routes of administration of drugs, to novel therapies. The remarkable versatility of the nervous system is highlighted.
Impulsivity is a behavioral trait characterized by an urge to act without thinking, as a result of a deficient inhibitory control [1]. Impulsivity has important consequences in the daily life of individuals and for society [2]). Impulsivity is common in various prevalent psychiatric disorders, such as obsessive–compulsive disorder, bipolar disorders, borderline disorders, ADHD and addictive disorders, and is seen as a transdiagnostic factor in psychiatry [3].
Both genetic and neurobiological mechanisms underlie impulsivity [2]. Neurotransmitters might play a key role in the pathogenesis, with an implication of the limbic cortico-striatal pathways [4,5]. In particular, it has been suggested that impulsivity is modulated by the activity of the serotoninergic/dopaminergic system, and a serotoninergic/dopaminergic dysfunction has been raised [6]. In victims of suicide, it has been demonstrated in post-mortem studies that pre-synaptic 5-HT transporter (5-HTT) binding and post-synaptic 5-HT2 receptor binding are reduced. A dysfunction of the serotonergic system would, for instance, explain the impulsive aggression in dogs [7]. Kim et al. have investigated serotonergic activity in impulsivity traits by applying in vivo techniques in healthy subjects assessed by the Barratt Impulsiveness Scale [8]. Using MRI and PET, they show that motor impulsiveness is correlated with 5-HT availability. Non-planning impulsivity was correlated with 5-HT2A receptor availability in the fronto-striatal circuits, amygdala, and insula. These results emphasize the importance of these regions of the brain in impulsivity [4].
Our personality is shaped by complex interactions between our genetic background and the environment [9]. The field of behavioral epigenetics has modified our understanding of the factors influencing personality [10]. Amongst the genes influencing our personality are those of the serotoninergic system, and it is established that genetic variants modulate this neurotransmission [11].
Lachowicz et al. have investigated the relationships between 5-HTTLPR (serotonin transporter-linked promoter region; serotonin transporter gene: SLC6A4) polymorphisms and personality traits [12]. They found significant associations between polymorphisms and neuroticism, openness, and conscientiousness. The study shows that 5-HTTLPR polymorphisms are involved in human personality. Genetic variations in the SLC6A4 gene tune personality.
The cerebellum contains more than 20 neuropeptides, and it is assumed that they exert a modulatory function in the cerebellar circuitry and tune the development of the cerebellum [13,14]. For instance, CRF is found in climbing fibers, and its release is needed for motor learning at the parallel fiber-Purkinje cell synapse and motor coordination of cerebellar nuclei [14,15]. Rats injected with CRF directly into the cerebellum show superior motor performance [16].
Li et al. have reviewed 8 key neuropeptides (including BDNF, CRF, neuropeptide Y, orexin, oxytocin, secretin), discussing their potential therapeutic roles for disorders involving the cerebellar circuitry or for the modulation of neurological/psychiatric disorders [17]. Overall, neuropeptides might be involved in several neurological or neuropsychiatric disorders.
The innervation of the human uterine cervix has received little attention. The cervix has a sensory, parasympathetic, and sympathetic innervation [18]. Nerve fibers show a centripetal path from the serosa to the endometrium, and innervation of the myometrium is rich [19]. The innervation is denser in the supra-vaginal cervix than in the body of the uterus.
Malvasi et al. have studied the presence of catecholamine neurofibers in the pregnant uterus [20]. They found higher concentrations of A nerve fibers in the internal uterine orifice as compared to the lower uterine segment. These fibers might act as a myometrial pacemaker. The sympathetic system might be activated by stressful conditions and contribute to dystocic labor.
As compared to oral administration or the intravenous route, the nose-to-brain delivery of drugs has major potential for the management of brain disorders. Small molecules may be delivered by the intranasal route to reach the central nervous system [21]. Drug-carriers must be biocompatible and show low toxicity [22]. Drug-carrying nanoparticles may be delivered via the mouth or the nose, with increased therapeutic effects as compared to systemic delivery, with a bypass of the blood–brain barrier [23,24]. Nanoemulsion technologies are emerging [24].
A study of intranasal administration of indocyanine green (ICG) shows transport via the olfactory and trigeminal nerves [22]. ICG-encapsulated PLGA nanoparticles are potential carriers for many substances that could be useful for neurological diseases. Intranasal administration of a dry powder could be used to cross the nasal barrier.
Glyphosate, an organic phosphonate, is a widely used herbicide with broad-spectrum activity. The molecule accumulates in the kidney, liver and gastrointestinal tract wall [25,26,27,28]. The mechanisms of neurotoxicity include altered neurotransmission, neuroinflammation, oxidative stress, and mitochondrial dysfunction [29]. Neuronal death results from autophagy, necrosis, or apoptosis.
Palus et al. show that oral exposure to glyphosate impairs the neurochemical profile of the enteric nervous system in the porcine jejunum in a dose-dependent manner [30], 2025). After 28 days of exposure, glyphosate increases the number of neurons expressing PACAP, CGRP, CART and nNOS, but decreases the VAChT-positive neurons. Effects are broadly uniform. The authors highlight the need to reassess regulatory guidelines. Doses leading to neurotoxic effects are lower than the limits established by regulatory agencies [29].
The Zika virus infection is a mosquito-borne virus causing severe neurodevelopmental disorders (Zika congenital syndrome: decreased thickness of cortical layers, brain calcifications, gliosis, ocular lesions) and Guillain-Barré syndrome, being a threat to public health [31,32,33,34]. The impaired autoimmunity is likely due to molecular mimicry [35]. The expression of genes involved in neurotransmission is impaired. Maternal Zika infection, even inapparent, is associated with increased synaptic density in the hippocampus [36]. Microglial activation is associated with synaptic loss [37].
Rengifo et al. have investigated how the Zika virus impairs the GABA/Glutamate system in mice [38]. In the final phase of the infection, data suggest that a loss of glutamate and GABA synthesis is increased, promoting viral replication by an immunosuppressive effect and contributing to the synaptopathy.
With the aging of the population, cognitive impairment is a matter of concern on a global scale [39,40]. The search for novel drugs enhancing memory remains an important topic of research [41]. Astragaloside (extracted from Astragalus mongholicus) inhibits acetylcholinesterase. The molecule reduces memory impairment induced by scopolamine, being potentially a memory-enhancing drug given the importance of the cholinergic system in memory [42]. The drug does not reduce the memory impairment triggered by LPS, suggesting that astragaloside does not reverse neuroinflammation. The molecule shows a protective effect on hippocampal neurons via an effect on the PPARgamma/BDNF pathway [43].
Over the past four decades, the study of neurotransmitters has undergone substantial conceptual evolution. Initial investigations were devoted to establishing peptides and related molecules as bona fide neurotransmitters. With the subsequent rise in molecular biology, the field shifted toward the identification and classification of receptor families, and later toward elucidating the relationships between receptor function and synaptic plasticity.
The contributions assembled in this Special Issue indicate that neurotransmitter research is now entering a further stage of development. As outlined above, neurotransmitters are increasingly being examined through their associations with behavior, pathological processes, and the modulation of neural function—perspectives that extend beyond traditional molecular or synaptic frameworks.
Taken together, the articles in this issue demonstrate the broadening scope of neurotransmitter research. They elucidate links between neurotransmitter systems and impulsivity or personality traits, reproductive physiology, alterations in neurotransmitter profiles induced by viral infection or toxic exposure, therapeutic modulation of cerebellar and cognitive functions, and drug delivery to the brain via the nasal route.
Collectively, these studies underscore that the field is advancing toward a more integrative phase in which chemical signaling is considered not only at the molecular level but also as a determinant of behavior, physiology, and disease. We trust that readers will recognize from this collection that neurotransmitter research has entered a new and consequential stage of scientific inquiry.
Author Contributions
Preparation, Writing, Editing: M.M., J.-N.Z. and H.M. All authors have read and agreed to the published version of the manuscript.
Institutional Review Board Statement
Not applicable.
Informed Consent Statement
This is an editorial article that does not involve patients.
Data Availability Statement
No new data were created or analyzed in this study. Data sharing is not applicable to this article.
Conflicts of Interest
The authors declare no conflicts of interest.
Funding Statement
This research received no external funding.
Footnotes
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
References
- 1.Bari A., Robbins T.W. Inhibition and impulsivity: Behavioral and neural basis of response control. Prog. Neurobiol. 2013;108:44–79. doi: 10.1016/j.pneurobio.2013.06.005. [DOI] [PubMed] [Google Scholar]
- 2.Hollander E., Rosen J. Impulsivity. J. Psychopharmacol. 2000;14:S39–S44. doi: 10.1177/02698811000142s106. [DOI] [PubMed] [Google Scholar]
- 3.Crisp Z.C., Grant J.E. Impulsivity across psychiatric disorders in young adults. Compr. Psychiatry. 2024;130:152449. doi: 10.1016/j.comppsych.2023.152449. [DOI] [PubMed] [Google Scholar]
- 4.Dalley J.W., Roiser J.P. Dopamine, serotonin and impulsivity. Neuroscience. 2012;215:42–58. doi: 10.1016/j.neuroscience.2012.03.065. [DOI] [PubMed] [Google Scholar]
- 5.Zhang X.Y., Peng S.Y., Shen L.P., Zhuang Q.X., Li B., Xie S.T., Li Q.X., Shi M.R., Ma T.Y., Zhang Q., et al. Targeting presynaptic H3 heteroreceptor in nucleus accumbens to improve anxiety and obsessive-compulsive-like behaviors. Proc. Natl. Acad. Sci. USA. 2020;117:32155–32164. doi: 10.1073/pnas.2008456117. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Dellu-Hagedorn F., Rivalan M., Fitoussi A., De Deurwaerdère P. Inter-individual differences in the impulsive/compulsive dimension: Deciphering related dopaminergic and serotonergic metabolisms at rest. Philos. Trans. R. Soc. Lond. B Biol. Sci. 2018;373:20170154. doi: 10.1098/rstb.2017.0154. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Peremans K., Audenaert K., Coopman F., Blanckaert P., Jacobs F., Otte A., Verschooten F., van Bree H., van Heeringen K., Mertens J., et al. Estimates of regional cerebral blood flow and 5-HT2A receptor density in impulsive, aggressive dogs with 99mTc-ECD and 123I-5-I-R91150. Eur. J. Nucl. Med. Mol. Imaging. 2003;30:1538–1546. doi: 10.1007/s00259-003-1250-x. [DOI] [PubMed] [Google Scholar]
- 8.Kim J.H., Kim H.K., Son Y.D., Kim J.H. The relationship between impulsivity traits and in vivo cerebral serotonin transporter and serotonin 2A receptor binding in healthy individuals: A double-tracer PET study with C-11 DASB and C-11 MDL100907. Int. J. Mol. Sci. 2024;26:252. doi: 10.3390/ijms26010252. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Caspi A., Roberts B.W., Shiner R.L. Personality development: Stability and change. Annu. Rev. Psychol. 2005;56:453–484. doi: 10.1146/annurev.psych.55.090902.141913. [DOI] [PubMed] [Google Scholar]
- 10.Moore D.S. Behavioral epigenetics. Wiley Interdiscip. Rev. Syst. Biol. Med. 2017;9:e1333. doi: 10.1002/wsbm.1333. [DOI] [PubMed] [Google Scholar]
- 11.Bruzzone S.E.P., Nasser A., Aripaka S.S., Spies M., Ozenne B., Jensen P.S., Knudsen G.M., Frokjaer V.G., Fisher P.M. Genetic contributions to brain serotonin transporter levels in healthy adults. Sci. Rep. 2023;13:16426. doi: 10.1038/s41598-023-43690-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Lachowicz M., Suchanecka A., Chmielowiec K., Boroń A., Chmielowiec J., Prabucka K., Rychel M., Pedrycz A., Recław R., Rahnama-Hezavah M., et al. Analysis of serotonin transporter gene 5-HTTLPR polymorphism and its impact on personality traits in a sample without neuropsychiatric or substance use disorders. Int. J. Mol. Sci. 2025;26:3718. doi: 10.3390/ijms26083718. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Kwong W.H., Chan W.Y., Lee K.K., Fan M., Yew D.T. Neurotransmitters, neuropeptides and calcium binding proteins in developing human cerebellum: A review. Histochem. J. 2000;32:521–534. doi: 10.1023/a:1004197210189. [DOI] [PubMed] [Google Scholar]
- 14.Ito M. Functional roles of neuropeptides in cerebellar circuits. Neuroscience. 2009;162:666–672. doi: 10.1016/j.neuroscience.2009.01.019. [DOI] [PubMed] [Google Scholar]
- 15.Wang Y., Chen Z.P., Zhuang Q.X., Zhang X.Y., Li H.Z., Wang J.J., Zhu J.N. Role of corticotropin-releasing factor in cerebellar motor control and ataxia. Curr. Biol. 2017;27:2661–2669. doi: 10.1016/j.cub.2017.07.035. [DOI] [PubMed] [Google Scholar]
- 16.Takeuchi E., Hatanaka T., Iijima T., Kimura M., Katoh A. The effects of corticotropin-releasing factor on motor learning. Sci. Rep. 2024;14:17056. doi: 10.1038/s41598-024-66736-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Li Z.H., Li B., Zhang X.Y., Zhu J.N. Neuropeptides and their roles in the cerebellum. Int. J. Mol. Sci. 2024;25:2332. doi: 10.3390/ijms25042332. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Giovannetti O., Tomalty D., Velikonja L., Jurkus C., Adams M.A. The human cervix: Comprehensive review of innervation and clinical significance. Clin. Anat. 2023;36:118–127. doi: 10.1002/ca.24023. [DOI] [PubMed] [Google Scholar]
- 19.Pinsard M., Mouchet N., Dion L., Bessede T., Bertrand M., Darai E., Bellaud P., Loget P., Mazaud-Guittot S., Morandi X., et al. Anatomic and functional mapping of human uterine innervation. Fertil. Steril. 2022;117:1279–1288. doi: 10.1016/j.fertnstert.2022.02.013. [DOI] [PubMed] [Google Scholar]
- 20.Malvasi A., Baldini G.M., Cicinelli E., Di Naro E., Baldini D., Favilli A., Quellari P.T., Sabbatini P., Fioretti B., Malgieri L.E., et al. Localization of catecholaminergic neurofibers in pregnant cervix as a possible myometrial pacemaker. Int. J. Mol. Sci. 2024;25:5630. doi: 10.3390/ijms25115630. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Shi Y., Zhang Y.X., Chen J.Y., Ma S., Xue W.X., Li W., Li Q.X., Song B., Li Y.T., Ma H.Y., et al. Targeting histamine H4 receptor in the rostral ventromedial medulla to relieve hypertension. Adv. Sci. 2025;12:e08176. doi: 10.1002/advs.202508176. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Mishonova M., Koceva L., Pilicheva B., Zagorchev P., Raikova N., Mladenov M., Konakchieva R., Gagov H., Sazdova I. Indocyanine green as a marker for nose-to-brain delivery pathways, brain distribution, and PLGA nanoparticle efficiency. Int. J. Mol. Sci. 2026;27:1782. doi: 10.3390/ijms27041782. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Alavian F., Shams N. Oral and intra-nasal administration of nanoparticles in the cerebral ischemia treatment in animal experiments: Considering its advantages and disadvantages. Curr. Clin. Pharmacol. 2020;15:20–29. doi: 10.2174/22123938otkzpotu1tcvy. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Alaayedi M.H., Maraie N.K. Lomustine’s nanoemulsion as nose-to-brain drug delivery system for CNS tumor treatment. Saudi Pharm. J. 2023;31:101692. doi: 10.1016/j.jsps.2023.06.025. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Marino M., Mele E., Viggiano A., Nori S.L., Meccariello R., Santoro A. Pleiotropic Outcomes of Glyphosate Exposure: From Organ Damage to Effects on Inflammation, Cancer, Reproduction and Development. Int. J. Mol. Sci. 2021;22:12606. doi: 10.3390/ijms222212606. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Gunatilake S., Seneff S., Orlando L. Glyphosate’s Synergistic Toxicity in Combination with Other Factors as a Cause of Chronic Kidney Disease of Unknown Origin. Int. J. Environ. Res. Public Health. 2019;16:2734. doi: 10.3390/ijerph16152734. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Abdelmagid A.D., Said A.M., Abd El-Gawad E.A., Shalaby S.A., Dawood M.A.O. Glyphosate-induced liver and kidney dysfunction, oxidative stress, immunosuppression in Nile tilapia, but ginger showed a protection role. Vet. Res. Commun. 2023;47:445–455. doi: 10.1007/s11259-022-09961-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Lu L., Liu J.B., Wang J.Q., Lian C.Y., Wang Z.Y., Wang L. Glyphosate-induced mitochondrial reactive oxygen species overproduction activates parkin-dependent mitophagy to inhibit testosterone synthesis in mouse leydig cells. Environ. Pollut. 2022;314:120314. doi: 10.1016/j.envpol.2022.120314. [DOI] [PubMed] [Google Scholar]
- 29.Costas-Ferreira C., Durán R., Faro L.R.F. Toxic Effects of Glyphosate on the Nervous System: A Systematic Review. Int. J. Mol. Sci. 2022;23:4605. doi: 10.3390/ijms23094605. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Palus K., Karpiesiuk A., Jana B. Neurochemical Remodelling of the Enteric Nervous System Neurons in the Porcine Jejunum Following Low-Dose Glyphosate Exposure. Int. J. Mol. Sci. 2025;26:9840. doi: 10.3390/ijms26209840. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Lopes Moreira M.E., Nielsen-Saines K., Brasil P., Kerin T., Damasceno L., Pone M., Carvalho L.M.A., Pone S.M., Vasconcelos Z., Ribeiro I.P., et al. Neurodevelopment in Infants Exposed to Zika Virus In Utero. N. Engl. J. Med. 2018;379:2377–2379. doi: 10.1056/nejmc1800098. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Nascimento O.J.M., da Silva I.R.F. Guillain-Barre syndrome and Zika virus outbreaks. Curr. Opin. Neurol. 2017;30:500–507. doi: 10.1097/wco.0000000000000471. [DOI] [PubMed] [Google Scholar]
- 33.Uncini A., Shahrizaila N., Kuwabara S. Zika virus infection and Guillain-Barre syndrome: A review focused on clinical and electrophysiological subtypes. J. Neurol. Neurosurg. Psychiatry. 2017;88:266–271. doi: 10.1136/jnnp-2016-314310. [DOI] [PubMed] [Google Scholar]
- 34.Rengifo A.C., Rivera J., Álvarez-Díaz D.A., Naizaque J., Santamaria G., Corchuelo S., Gómez C.Y., Torres-Fernández O. Morphological and Molecular Changes in the Cortex and Cerebellum of Immunocompetent Mice Infected with Zika Virus. Viruses. 2023;15:1632. doi: 10.3390/v15081632. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Katz I., Gilburd B., Shovman O. Zika autoimmunity and Guillain-Barre syndrome. Curr. Opin. Rheumatol. 2019;31:484–487. doi: 10.1097/bor.0000000000000629. [DOI] [PubMed] [Google Scholar]
- 36.Chou T.W., McCourt M., Marmut E., Karuppusamy V., Lindman M., Estevez I., Buckley B.D., Thackray J.K., Rodriguez K., Nissenbaum M., et al. Inapparent maternal ZIKV infection impacts fetal brain development and postnatal behavior. PLoS Pathog. 2026;22:e1013850. doi: 10.1371/journal.ppat.1013850. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Kim N., Choi H., Kim U., Kim S., Kim Y.B., Shin H.Y. Sustained Microglial Activation Promotes Synaptic Loss and Neuronal Dysfunction after Recovery from ZIKV Infection. Int. J. Mol. Sci. 2024;25:9451. doi: 10.3390/ijms25179451. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Rengifo A.C., Naizaque J., Santamaría G., Alvarez-Díaz D.A., Rodriguez A.V., Guío-Vega G., Rivera J., Castro C.E., Dueñas Z., Torres-Fernández O. Alterations in the Components of the GABA-Glutamate System During ZIKV Infection: A Neuroscience Approach. Int. J. Mol. Sci. 2026;27:4833. doi: 10.3390/ijms27114833. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Juan S.M.A., Adlard P.A. Ageing and Cognition. Subcell. Biochem. 2019;91:107–122. doi: 10.1007/978-981-13-3681-2_5. [DOI] [PubMed] [Google Scholar]
- 40.Rajan K.B., Weuve J., Barnes L.L., McAninch E.A., Wilson R.S., Evans D.A. Population estimate of people with clinical Alzheimer’s disease and mild cognitive impairment in the United States (2020–2060) Alzheimers Dement. 2021;17:1966–1975. doi: 10.1002/alz.12362. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Se Thoe E., Fauzi A., Tang Y.Q., Chamyuang S., Chia A.Y.Y. A review on advances of treatment modalities for Alzheimer’s disease. Life Sci. 2021;276:119129. doi: 10.1016/j.lfs.2021.119129. [DOI] [PubMed] [Google Scholar]
- 42.Stępnik K., Kukula-Koch W., Boguszewska-Czubara A., Gawel K. Astragaloside IV as a Memory-Enhancing Agent: In Silico Studies with In Vivo Analysis and Post Mortem ADME-Tox Profiling in Mice. Int. J. Mol. Sci. 2024;25:4021. doi: 10.3390/ijms25074021. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Wang X., Xu W., Chen H., Li W., Li W., Zhu G. Astragaloside IV prevents Abeta(1-42) oligomers-induced memory impairment and hippocampal cell apoptosis by promoting PPARgamma/BDNF signaling pathway. Brain Res. 2020;1747:147041. doi: 10.1016/j.brainres.2020.147041. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
No new data were created or analyzed in this study. Data sharing is not applicable to this article.
